Interestingly, PEG10 is a biomarker for progressive development and invasion of hepatocellular carcinoma, gallbladder adenocarcinoma and acute lymphoid leukemia and is found to be regulated by androgens [47], [48], [49], [50]. This evidence concerns the gene PEG10 and gallbladder adenocarcinoma.